Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript
|
ELI LILLY & Co (LLY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/07/2023 |
3
| ELI LILLY & Co (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc. |
01/03/2023 |
3
| Dozier Eric (EVP, HR & Diversity) has filed a Form 3 on ELI LILLY & Co |
10/27/2022 |
3
| Kearny Acquisition Corp (10% Owner) has filed a Form 3 on Akouos, Inc. |
05/16/2022 |
3
| Hedley Mary Lynne (Director) has filed a Form 3 on ELI LILLY & Co |
09/07/2021 |
3
| Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC) has filed a Form 3 on ELI LILLY & Co |
06/30/2021 |
3
| Weems Alonzo (SVP, ERM & CECO) has filed a Form 3 on ELI LILLY & Co |
05/19/2021 |
3
| Rau Diogo (SVP & CIDO) has filed a Form 3 on ELI LILLY & Co |
05/10/2021 |
3
| Hernandez Edgardo (SVP & Pres., Mfg. Operations) has filed a Form 3 on ELI LILLY & Co |
02/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/10/2021 |
3
| Ashkenazi Anat (SVP & CFO) has filed a Form 3 on ELI LILLY & Co |
02/02/2021 |
3
| Sulzberger Gabrielle (Director) has filed a Form 3 on ELI LILLY & Co |
12/16/2020 |
3
| Tyto Acquisition Corp (10% Owner) has filed a Form 3 on Prevail Therapeutics Inc. |
12/03/2020 |
3
| ELI LILLY & Co (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc. |
10/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/11/2020 |
3
| ELI LILLY & Co (10% Owner) has filed a Form 3 on Avidity Biosciences, Inc. |
02/07/2020 |
3
| Hakim Anat (Senior VP & General Counsel) has filed a Form 3 on ELI LILLY & Co |
01/10/2020 |
3
| Bald Eagle Acquisition Corp (10% Owner) has filed a Form 3 on Dermira, Inc. |
01/09/2020 |
3
| Mason Michael B (Sr. VP & Pres., Lilly Diabetes) has filed a Form 3 on ELI LILLY & Co |
09/05/2019 |
3
| Jonsson Patrik (SVP and Pres., Lilly Bio-Meds) has filed a Form 3 on LILLY ELI & CO |
12/04/2018 |
3
| Walker Karen (Director) has filed a Form 3 on LILLY ELI & CO |
09/19/2018 |
3
| LILLY ELI & CO (10% Owner) has filed a Form 3 on Elanco Animal Health Inc |
09/07/2018 |
3
| White Anne E. (SVP & Pres-Lilly Oncology) has filed a Form 3 on LILLY ELI & CO |
06/11/2018 |
3
| Skovronsky Daniel (SVP, CSO, and Pres. LRL) has filed a Form 3 on LILLY ELI & CO |
02/14/2018 |
3
| LILLY ELI & CO (10% Owner) has filed a Form 3 on Zymeworks Inc. |
01/10/2018 |
3
| Smiley Joshua L (SVP and CFO) has filed a Form 3 on LILLY ELI & CO |
01/10/2018 |
3
| O'Neill Myles (SVP & Pres., Mfg. Operations) has filed a Form 3 on LILLY ELI & CO |
01/10/2018 |
3
| Shah Aarti S. (SVP & CIO) has filed a Form 3 on LILLY ELI & CO |
11/16/2017 |
3
| LILLY ELI & CO (10% Owner) has filed a Form 3 on LEAP THERAPEUTICS, INC. |
06/13/2017 |
3
| Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) has filed a Form 3 on LILLY ELI & CO |
04/10/2017 |
3
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 3 on LILLY ELI & CO |
04/10/2017 |
3
| Norton Johna (Senior VP, Global Quality) has filed a Form 3 on LILLY ELI & CO |
02/23/2017 |
3
| Bertozzi Carolyn R (Director) has filed a Form 3 on LILLY ELI & CO |
01/27/2017 |
3
| LILLY ELI & CO (10% Owner) has filed a Form 3 on CoLucid Pharmaceuticals, Inc. |
10/04/2016 |
3
| JACKSON JAMERE (Director) has filed a Form 3 on LILLY ELI & CO |
|
|
|